Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Condition: Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder
NCT05312671
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.